# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001628280-25-031455
Filing Date
2025-06-16
Accepted
2025-06-16 07:48:32
Documents
17
Period of Report
2025-06-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | aqst-20250613.htm iXBRL | 8-K | 28194
2 | EX-99.1 | prndaacceptancedraft6-13.htm | EX-99.1 | 14087
6 |  | prndaacceptancedraft6-13001.jpg | GRAPHIC | 229018
7 |  | prndaacceptancedraft6-13002.jpg | GRAPHIC | 248380
8 |  | prndaacceptancedraft6-13003.jpg | GRAPHIC | 291797
9 |  | prndaacceptancedraft6-13004.jpg | GRAPHIC | 217719
| Complete submission text file | 0001628280-25-031455.txt |  | 1523369

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | aqst-20250613.xsd | EX-101.SCH | 1776
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | aqst-20250613_lab.xml | EX-101.LAB | 21629
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | aqst-20250613_pre.xml | EX-101.PRE | 12504
19 | EXTRACTED XBRL INSTANCE DOCUMENT | aqst-20250613_htm.xml | XML | 2719

Mailing Address 30 TECHNOLOGY DRIVE WARREN NJ 07059
Business Address 30 TECHNOLOGY DRIVE WARREN NJ 07059 908-941-1900
Aquestive Therapeutics, Inc. (Filer) CIK: 0001398733 (see all company filings)

EIN.: 208623253 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38599 | Film No.: 251048552
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)